HHS cancels funding for Moderna bird flu vaccine
Digest more
The Trump administration’s decision to yank nearly $600 million in promised bird flu vaccine funding is the latest worrying sign for Moderna.
For many Americans, it's not clear how easy getting a COVID-19 vaccination this fall will be — or if they've lost the choice. Health Secretary Robert F.
CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: Jefferies Global Health Care Conference,
Explore more